Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.21 USD
Change Today 0.00 / 0.00%
Volume 0.0
RGDO On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

regado bioscience inc (RGDO) Snapshot

Open
$1.21
Previous Close
$10.89
Day High
$1.25
Day Low
$1.18
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for REGADO BIOSCIENCE INC (RGDO)

Related News

No related news articles were found.

regado bioscience inc (RGDO) Related Businessweek News

No Related Businessweek News Found

regado bioscience inc (RGDO) Details

As of May 4, 2015, Regado Biosciences, Inc. was acquired by Tobira Therapeutics, Inc., in a reverse merger transaction. Regado Biosciences, Inc., a biopharmaceutical company, focuses on the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular and other indications. The company was formerly known as Quartet Biosciences, Inc. and changed its name to Regado Biosciences, Inc. in March 2003. Regado Biosciences, Inc. was founded in 2001 and is headquartered in Basking Ridge, New Jersey.

4 Employees
Last Reported Date: 02/12/15
Founded in 2001

regado bioscience inc (RGDO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

regado bioscience inc (RGDO) Key Developments

Regado Biosciences, Inc., Special/Extraordinary Shareholders Meeting, May 04, 2015

Regado Biosciences, Inc., Special/Extraordinary Shareholders Meeting, May 04, 2015. Agenda: To approve the issuance of Regado common stock pursuant to the agreement and plan of merger and reorganization.

Regado Biosciences, Inc. Announces Board Changes

On February 27, 2015, the Board of Regado Biosciences, Inc. accepted the resignations of B. Jefferson Clark, Anton Gopka, Michael E. Mendelsohn, P. Sherrill Neff, Jesse Treu and Michael Metzger as members of the Board, including as members of any committees or subcommittees of the Board, as applicable, which resignations will be effective as of, and conditioned on, the effective time of the Merger. Mr. Fromkin will continue to serve on the audit committee of the Board and will serve as chair of the compensation committee of the Board, subject to and upon the effective time of the Merger. Mr. Legault will continue to serve as chair of the audit committee. On February 27, 2015, the Board approved the appointment of each of Patrick Heron and Carol L. Brosgart, M.D. to fill the vacancies left by the Class I directors of the company, each of Eckard Weber, M.D., Jeffrey H. Cooper and Gwen A. Melincoff to fill the vacancies left by the Class II directors of the company, and Laurent Fischer, M.D. to fill the vacancy left by the Class III directors of the company, which appointments will be effective as of, and conditioned on, the effective time of the Merger. Patrick Heron has served as a member of Tobira’s board of directors since March 2007. Carol L. Brosgart, M.D, has served as a member of Tobira’s board of directors since September 2009.

Regado Biosciences, Inc., Tobira Therapeutics, Inc. - M&A Call

To discuss the merger agreement

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGDO:US $1.21 USD 0.00

RGDO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RGDO.
View Industry Companies
 

Industry Analysis

RGDO

Industry Average

Valuation RGDO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 28.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGADO BIOSCIENCE INC, please visit www.regadobio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.